Sanofi : EU Approves Dupixent To Treat Severe Atopic Dermatitis In Children
21/3 07:47
(RTTNews) - The European Commission approved Dupixent or dupilumab to treat severe atopic dermatitis in children aged 6 months to 5 years old who are candidates for systemic therapy, Sanofi - Aventis Groupe said in a statement on Tuesday....